Dimitris N Kiosses1, Jody Monkovic2, Amy Stern2, Sara J Czaja3, George Alexopoulos2, Elizabeth Arslanoglou2, Theresa Ebo2, Joanna Pantelides2, Huaian Yu2, Jacob Dunefsky2, Anna Smeragliuolo4, David Putrino5. 1. Weill Cornell Medicine, Department of Psychiatry (DNK, JM, AS, GA, EA, TE, JP, HY, JD), Weill Cornell Institute of Geriatric Psychiatry, White Plains, NY. Electronic address: dkiosses@med.cornell.edu. 2. Weill Cornell Medicine, Department of Psychiatry (DNK, JM, AS, GA, EA, TE, JP, HY, JD), Weill Cornell Institute of Geriatric Psychiatry, White Plains, NY. 3. Weill Cornell Medicine, Division of Geriatrics and Palliative Medicine (SJC), Center on Aging and Behavioral Research, New York, NY. 4. Burke Rehabilitation Hospital (AS), White Plains, NY. 5. Icahn School of Medicine at Mount Sinai (DP), New York, NY.
Abstract
OBJECTIVE: The unique features of technological applications may improve the treatment of people at risk of suicide. In this article, we present feasibility and acceptability data as well as two case studies demonstrating the use of WellPATH, a tablet app that aims to help suicidal patients during emotionally-charged situations outside of therapy sessions. The WellPATH app was part of a 12-week psychotherapy intervention (CRISP - Cognitive Reappraisal Intervention for Suicide Prevention) for middle-aged and older adults after their discharge from a suicide-related hospitalization. DESIGN: The use of WellPATH includes three stages: preparation and practice, incorporation, and actual use. MEASUREMENTS: Feasibility was measured by the overall use of WellPATH during 12 weeks, and acceptability was measured with the three items of the Client Satisfaction Questionnaire. RESULTS: Twelve study participants were administered WellPATH as part of CRISP. The results provide preliminary evidence of feasibility and acceptability of WellPATH. Study participants and therapists reported high satisfaction with WellPATH and provided feedback for future research and development. The patients in the case studies reported a reduction in negative emotions and an increase in emotion regulation (i.e., cognitive reappraisal ability) after using techniques on the WellPATH app. CONCLUSION: Our preliminary findings suggest that use of technology applications such as the WellPATH app is feasible and accepted among middle-aged and older adults at high suicide risk. Further research with an adequately powered sample is needed to further evaluate WellPATH's feasibility and accessibility, and test its efficacy with this high-risk population.
OBJECTIVE: The unique features of technological applications may improve the treatment of people at risk of suicide. In this article, we present feasibility and acceptability data as well as two case studies demonstrating the use of WellPATH, a tablet app that aims to help suicidal patients during emotionally-charged situations outside of therapy sessions. The WellPATH app was part of a 12-week psychotherapy intervention (CRISP - Cognitive Reappraisal Intervention for Suicide Prevention) for middle-aged and older adults after their discharge from a suicide-related hospitalization. DESIGN: The use of WellPATH includes three stages: preparation and practice, incorporation, and actual use. MEASUREMENTS: Feasibility was measured by the overall use of WellPATH during 12 weeks, and acceptability was measured with the three items of the Client Satisfaction Questionnaire. RESULTS: Twelve study participants were administered WellPATH as part of CRISP. The results provide preliminary evidence of feasibility and acceptability of WellPATH. Study participants and therapists reported high satisfaction with WellPATH and provided feedback for future research and development. The patients in the case studies reported a reduction in negative emotions and an increase in emotion regulation (i.e., cognitive reappraisal ability) after using techniques on the WellPATH app. CONCLUSION: Our preliminary findings suggest that use of technology applications such as the WellPATH app is feasible and accepted among middle-aged and older adults at high suicide risk. Further research with an adequately powered sample is needed to further evaluate WellPATH's feasibility and accessibility, and test its efficacy with this high-risk population.
Authors: Line Iden Berge; Marie Hidle Gedde; Juan Carlos Torrado Vidal; Bettina Husebo; Kia Minna Hynninen; Solgunn Elisabeth Knardal; Kristine Gustavsen Madsø Journal: Front Psychiatry Date: 2022-08-18 Impact factor: 5.435